Vasculitis in the geriatric population

Clinics in Geriatric Medicine

Volumn 21, Issue 3 SPEC. ISS., 2005, Pages 631-647

  Langford, Carol A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLOPURINOL; ANTIHISTAMINIC AGENT; ANTIVIRUS AGENT; ATOVAQUONE; AZATHIOPRINE; COLCHICINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; DAPSONE; GLUCOCORTICOID; HYDRALAZINE; IMMUNOSUPPRESSIVE AGENT; INACTIVATED VACCINE; INFLUENZA VACCINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MEPREDNISONE; METHOTREXATE; MINOCYCLINE; NEUTROPHIL CYTOPLASMIC ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PENTAMIDINE; PREDNISONE; PROPYLTHIOURACIL; SULFALAZINE;

ALLERGIC VASCULITIS; ANAPHYLACTOID PURPURA; ARTERIOGRAPHY; BLADDER CARCINOMA; BLADDER INJURY; BLOOD VESSEL BIOPSY; BONE MARROW SUPPRESSION; CATARACT; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; CRYOGLOBULINEMIC VASCULITIS; CYTOPENIA; DIABETES MELLITUS; DISEASE COURSE; DRUG HYPERSENSITIVITY; ERYTHROCYTE SEDIMENTATION RATE; GERIATRICS; GIANT CELL ARTERITIS; GOUT; HUMAN; HYPERTENSION; INFECTION; INFERTILITY; INFLUENZA; MYELOPROLIFERATIVE DISORDER; MYOPATHY; NECROTIZING ARTERITIS; NEPHROTOXICITY; PHYSICAL EXAMINATION; PLASMAPHERESIS; PNEUMONIA; POLYARTERITIS NODOSA; REVIEW; RHEUMATIC POLYMYALGIA; SIDE EFFECT; SMALL VESSEL VASCULITIS; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 19344373420     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2005.02.011     Document Type: Review

References (99)

1. A. Kussmaul, and K. Maier Uber eine bischer nicht beschreibene eigenthumliche Arterienekrankkung (Periarteritis nodosa), die mit Morbus Brightii und rpaid fortschreitender allgemeiner Muskellahmung einhergeht Dtsch Arch Klin 1 1866 484 517
2. P.M. Zeek Periarteritis nodosa: critical review Am J Clin Pathol 22 1952 777 790
3. J.C. Jennette, R.J. Falk, and K. Andrassy Nomenclature of systemic vasculitides. Proposal of an international consensus conference Arthritis Rheum 37 2 1994 187 192
4. R.A. Watts, and D.G. Scott Classification and epidemiology of the vasculitides Baillieres Clin Rheumatol 11 2 1997 191 217
5. C.M. Weyand, and J.J. Goronzy Giant-cell arteritis and polymyalgia rheumatica Ann Intern Med 139 6 2003 505 515
6. C. Salvarani, F. Cantini, and L. Boiardi Polymyalgia rheumatica and giant-cell arteritis N Engl J Med 347 4 2002 261 271
7. C. Salvarani, C.S. Crowson, and W.M. O'Fallon Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period Arthritis Rheum 51 2 2004 264 268
8. K.T. Calamia, and G.G. Hunder Clinical manifestations of giant cell (temporal) arteritis Clin Rheum Dis 6 1980 389 403
9. P.D. Aiello, J.C. Trautmann, and T.J. McPhee Visual prognosis in giant cell arteritis Ophthalmology 100 4 1993 550 555
10. S.S. Hayreh, P.A. Podhajsky, and B. Zimmerman Ocular manifestations of giant cell arteritis Am J Ophthalmol 125 4 1998 509 520
11. A. Brack, V. Martinez-Taboada, and A. Stanson Disease pattern in cranial and large-vessel giant cell arteritis Arthritis Rheum 42 2 1999 311 317
12. A.A. Achkar, J.T. Lie, and G.G. Hunder How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 120 12 1994 987 992
13. N.C. Birkhead, H.P. Wagener, and R.M. Shick Treatment of temporal arteritis with adrenal corticosteroids JAMA 163 1957 821 827
14. A.B. Myles, T. Perera, and M.G. Ridley Prevention of blindness in giant cell arteritis by corticosteroid treatment Br J Rheumatol 31 1992 103 105
15. R.W. Ross Russell Giant cell arteritis QJM 112 1959 471 489
16. G.T. Liu, J.S. Glaser, and N.J. Schatz Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision Ophthalmology 101 11 1994 1779 1785
17. P. Fauchald, O. Rygvold, and B. Oystase Temporal arteritis and polymyalgia rheumatica. Clinical and biopsy findings Ann Intern Med 77 1972 845 852
18. K.A. Huston, G.G. Hunder, and J.T. Lie Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study Ann Intern Med 88 1978 162 167
19. S. Sorensen, and I. Lorenzen Giant-cell arteritis, temporal arteritis and polymyalgia rheumatica. A retrospective study of 63 patients Acta Med Scand 201 3 1977 207 213
20. B.A. Bengtsson, and B.E. Malmvall Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids Acta Med Scand 209 5 1981 337 345
21. I. Lundberg, and E. Hedfors Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis J Rheumatol 17 1990 1340 1345
22. L. Fernandez-Herlihy Duration of corticosteroid therapy in giant cell arteritis J Rheumatol 7 3 1980 361 364
23. J.A. Jover, C. Hernandez-Garcia, and I.C. Morado Combined treatment of giant-cell arteritis with methotrexate and prednisone. a randomized, double-blind, placebo-controlled trial Ann Intern Med 134 2 2001 106 114
24. G.S. Hoffman, M.C. Cid, and D.B. Hellmann A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis Arthritis Rheum 46 5 2002 1309 1318
25. G. Nesher, Y. Berkun, and M. Mates Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis Arthritis Rheum 50 4 2004 1332 1337
26. J.M. Evans, C.A. Bowles, and J. Bjornsson Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases Arthritis Rheum 37 10 1994 1539 1547
27. J.M. Evans, W.M. O'Fallon, and G.G. Hunder Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study Ann Intern Med 122 7 1995 502 507
28. C. Salvarani, F. Cantini, and L. Boiardi Polymyalgia rheumatica Best Pract Res Clin Rheumatol 18 5 2004 705 722
29. T.Y. Chuang, G.G. Hunder, and D.M. Ilstrup Polymyalgia rheumatica: a 10-year epidemiologic and clinical study Ann Intern Med 97 5 1982 672 680
30. C.M. Weyand, N. Tetzlaff, and J. Bjornsson Disease patterns and tissue cytokine profiles in giant cell arteritis Arthritis Rheum 40 1 1997 19 26
31. C.M. Weyand, K.C. Hicok, and G.G. Hunder Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis Ann Intern Med 121 7 1994 484 491
32. C.M. Weyand, J.W. Fulbright, and J.M. Evans Corticosteroid requirements in polymyalgia rheumatica Arch Intern Med 159 6 1999 577 584
33. R. Caporali, M.A. Cimmino, and G. Ferraccioli Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial Ann Intern Med 141 7 2004 493 500
34. J.H. Stone Methotrexate in polymyalgia rheumatica: kernel of truth or curse of Tantalus? Ann Intern Med 141 7 2004 568 569
35. L. Guillevin, F. Lhote, and L. Guillevin Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment Curr Opin Rheumatol 7 1 1995 20 24
36. R.A. Watts, V.A. Jolliffe, and D.M. Carruthers Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis Arthritis Rheum 39 7 1996 1208 1212
37. L. Guillevin, H. Visser, and L.H. Noel Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome-62 patients J Rheumatol 20 8 1993 1345 1349
38. A.S. Fauci, J.L. Doppman, and S.M. Wolff Cyclophosphamide-induced remissions in advanced polyarteritis nodosa Am J Med 64 1978 890 894
39. M. Gayraud, L. Guillevin, and P. le Toumelin Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients Arthritis Rheum 44 3 2001 666 675
40. L. Guillevin, and F. Lhote Treatment of polyarteritis nodosa and microscopic polyangiitis Arthritis Rheum 41 12 1998 2100 2105
41. L. Guillevin, F. Lhote, and M. Gayraud Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients Medicine (Baltimore) 75 1 1996 17 28
42. L. Guillevin, F. Lhote, and R. Gherardi The spectrum and treatment of virus-associated vasculitides Curr Opin Rheumatol 9 1 1997 31 36
43. L. Guillevin, F. Lhote, and P. Cohen Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients Medicine (Baltimore) 74 5 1995 238 253
44. L. Guillevin, F. Lhote, and F. Sauvaget Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges Ann Rheum Dis 53 5 1994 334 337
45. L. Guillevin, F. Lhote, and A. Leon Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients J Rheumatol 20 1993 289 298
46. G.S. Hoffman, G.S. Kerr, and R.Y. Leavitt Wegener granulomatosis: an analysis of 158 patients Ann Intern Med 116 6 1992 488 498
47. E. Reinhold-Keller, N. Beuge, and U. Latza An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients Arthritis Rheum 43 5 2000 1021 1032
48. M. Tidman, R. Olander, and C. Svalander Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies J Intern Med 244 2 1998 133 141
49. R.A. Watts, S.E. Lane, and G. Bentham Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom Arthritis Rheum 43 2 2000 414 419
50. F.J. van der Woude, N. Rasmussen, and S. Lobatto Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis Lancet 1 8426 1985 425 429
51. G.S. Hoffman, and U. Specks Antineutrophil cytoplasmic antibodies Arthritis Rheum 41 9 1998 1521 1537
52. J.L. Niles, R.T. McCluskey, and M.F. Ahmad Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase Blood 74 6 1989 1888 1893
53. R.J. Falk, and J.C. Jennette Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis N Engl J Med 318 25 1988 1651 1657
54. B. Nölle, U. Specks, and J. Lüdemann Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis Ann Intern Med 111 1989 28 40
55. M.M. Boomsma, C.A. Stegeman, and M.J. van der Leij Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study Arthritis Rheum 43 9 2000 2025 2033
56. G.S. Kerr, T.A. Fleisher, and C.W. Hallahan Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis Arthritis Rheum 36 3 1993 365 371
57. R.J. Falk, and J.C. Jennette ANCA are pathogenic-oh yes they are! J Am Soc Nephrol 13 7 2002 1977 1979
58. K.A. Russell, and U. Specks Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenon Rheum Dis Clin North Am 27 4 2001 815 832
59. W.D. Travis, G.S. Hoffman, and R.Y. Leavitt Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients Am J Surg Pathol 15 1991 315 333
60. K.O. Devaney, W.D. Travis, and G.S. Hoffman Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients Am J Surg Pathol 14 1990 555 564
61. J.C. Jennette, and R.J. Falk The pathology of vasculitis involving the kidney Am J Kidney Dis 24 1 1994 130 141
62. A. Fauci, and S. Wolff Wegener's granulomatosis: studies in eighteen patients and a review of the literature Medicine 52 1973 535 561
63. A. Fauci, B. Haynes, and P. Katz Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years Ann Intern Med 98 1983 76 85
64. C.A. Langford, C. Talar-Williams, and K.S. Barron Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse Am J Med 114 6 2003 463 469
65. D. Jayne, N. Rasmussen, and K. Andrassy A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies N Engl J Med 349 1 2003 36 44
66. C. Talar-Williams, Y.M. Hijazi, and M.M. Walther Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis Ann Intern Med 124 5 1996 477 484
67. E. Reinhold-Keller, C.O. Fink, and K. Herlyn High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate Arthritis Rheum 47 3 2002 326 332
68. M.C. Sneller, G.S. Hoffman, and C. Talar-Williams An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone Arthritis Rheum 38 5 1995 608 613
69. C.A. Stegeman, J.W. Cohen Tervaert, and P.E. de Jong Trimethoprim- sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis N Engl J Med 335 1 1996 16 20
70. J.A. Govert, S. Patton, and R.L. Fine Pancytopenia from using trimethoprim and methotrexate Ann Intern Med 117 10 1992 877 878
71. L. Guillevin, B. Durand-Gasselin, and R. Cevallos Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients Arthritis Rheum 42 3 1999 421 430
72. C.O. Savage, C.G. Winearls, and D.J. Evans Microscopic polyarteritis: presentation, pathology and prognosis Q J Med 56 220 1985 467 483
73. P.H. Nachman, S.L. Hogan, and J.C. Jennette Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis J Am Soc Nephrol 7 1 1996 33 39
74. J. Churg, and L. Strauss Allergic granulomatosis, allergic angiitis and periarteritis nodosa Am J Pathol 27 1951 277 301
75. L. Guillevin, P. Cohen, and M. Gayraud Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients Medicine (Baltimore) 78 1 1999 26 37
76. J.G. Lanham, K.B. Elkon, and C.D. Pusey Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome Medicine (Baltimore) 63 2 1984 65 81
77. L.C. Chumbley, E.G. Harrison Jr, and R.A. DeRemee Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases Mayo Clin Proc 52 8 1977 477 484
78. P.F. Weller, M. Plaut, and V. Taggart The relationship of asthma therapy and Churg-Strauss syndrome: NIH workshop summary report J Allergy Clin Immunol 108 2 2001 175 183
79. J.H. Stone, and H.C. Nousari Essential cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin Curr Opin Rheumatol 13 1 2001 23 34
80. T. Lotti, I. Ghersetich, and C. Comacchi Cutaneous small-vessel vasculitis J Am Acad Dermatol 39 5 Pt 1 1998 667 687 [quiz 88-90]
81. L.E. Gibson Cutaneous vasculitis: appraoch to diagnosis and systemic associations Mayo Clin Proc 65 1990 221 229
82. F.T. Saulsbury Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature Medicine (Baltimore) 78 6 1999 395 409
83. G.B. Fogazzi, S. Pasquali, and M. Moriggi Long-term outcome of Schonlein-Henoch nephritis in the adult Clin Nephrol 31 2 1989 60 66
84. H.S. Ballard, R.P. Eisenger, and G. Gallo Renal manifestations of Henoch-Schonlein syndrome in adults Am J Med 49 1970 328 335
85. R. Blanco, V.M. Martinez-Taboada, and V. Rodriguez-Valverde Henoch-Schonlein purpura in adulthood and childhood: two different expressions of the same syndrome Arthritis Rheum 40 5 1997 859 864
86. H.K. Choi, P.A. Merkel, and A.M. Walker Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies Arthritis Rheum 43 2 2000 405 413
87. P. Lamprecht, A. Gause, and W.L. Gross Cryoglobulinemic vasculitis Arthritis Rheum 42 12 1999 2507 2516
88. V. Agnello, and P.L. Romain Mixed cryoglobulinemia secondary to hepatitis C virus infection Rheum Dis Clin North Am 22 1 1996 1 21
89. D. Vassilopoulos, and L.H. Calabrese Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies Arthritis Rheum 46 3 2002 585 597
90. F. Dammacco, D. Sansonno, and J.H. Han Natural interferon-alpha versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study Blood 84 10 1994 3336 3343
91. G. Nesher, M. Sonnenblick, and Y. Friedlander Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients J Rheumatol 21 7 1994 1283 1286
92. L. Guillevin, J.F. Cordier, and F. Lhote A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis Arthritis Rheum 40 12 1997 2187 2198
93. E.L. Matteson, K.N. Gold, and D.A. Bloch Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort Am J Med 101 2 1996 129 134
94. F.P. Ognibene, J.H. Shelhamer, and G.S. Hoffman Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis Am J Respir Crit Care Med 151 3 Pt 1 1995 795 799
95. H. Masur Prevention and treatment of pneumocystis pneumonia N Engl J Med 327 26 1992 1853 1860
96. S.E. Gabriel, J. Sunku, and C. Salvarani Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica Arthritis Rheum 40 10 1997 1873 1878
97. G. Pearce, P.F. Ryan, and P.D. Delmas The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica Br J Rheumatol 37 3 1998 292 299
98. A. el-Gamel, C. Evans, and B. Keevil Effect of allopurinol on the metabolism of azathioprine in heart transplant patients Transplant Proc 30 4 1998 1127 1129
99. D. Prager, M. Rosman, and J.R. Bertino Letter: azathioprine and allopurinol Ann Intern Med 80 3 1974 427